“Colistin As A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter Baumannii In Vivo and In Vitro”. 2022. Baghdad Science Journal 19 (2): 0255. https://doi.org/10.21123/bsj.2022.19.2.0255.